CARDIEX Limited (ASX:CDX) (CARDIEX, the Company) is pleased to announce the successful completion of two significant milestones in the commercialization of its wearable biomarker technology. Successful Completion of HEARTsense Wearable Study. The Company has successfully completed its primary study validating the use of its SphygmoCor® biomarker technology in wearables by…